3Lemos JA,Mc Guire DK,Drazner MH.B-type natriuretic peptide in cardiovascular disease[J].Lancet,2003,355:1126.
4Wang X,Li MX,Sykes BD.Structure of the regulatory N-domain of human cardiac troponin C in complex with human cardiac troponin I 147-163 and bepridil[J].J Biol Chem,2002,277(34):31124-31133.
5Cleland JC,McGown J.Levosimendan:a new era for inodilator therapy for heart failure[J].Curr Opin Cardiol,2002,17(3):257-265.
6McComb JM,McMaster EA,McKenzie G,et al.Myoglobin and creatine kinase in acute myocardial infarction[J].Br.Heart J,1984,51(2):189-194.
7Schulz O,Kromer AL.Cardiac troponin I:a pot marker of exercise intolerance in patient s wit h moderate heart failure[J].Am Heart J,2002,144:351-358.
8Horwich TB,Patel J,Madellam WR,et al. Cardiac t roponin I is associated wit h impaired hemodynamics,prognossive left vent ricular dysfunction and increased mortality rates in advanced heart failure[J].Circulation,2003,108:833-838.
9Sato Y,Taniguchi R,Makiyama T,et al.Measurement s of serum cardiact roponin T and plasma brain nat riuretic peptide in patient s wit h severe cardiac decompensation[J].Heart,2002,88:647-648.
